TreeFrog Therapeutics
PrivateLast Round
Debt
May 27, 2025
Total Funding Raised
$121.88M
Company Overview
Treefrog Therapeutics is a biotechnology company that offers a proprietary technology platform for alternative access to cell therapies, providing a comprehensive 3D scalable service that lowers treatment costs and enhances production quality, clinical development speed, and market access for safe and affordable stem cell therapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TreeFrog Therapeutics Comps
Public and private peers based on sector, stage, and business model.
TreeFrog Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | May 27, 2025 | ||||
| Corporate Funding | Apr 23, 2024 | ||||
| Series B | Sep 13, 2021 | ||||
| Grant | Sep 5, 2019 | ||||
| Series A | May 13, 2019 | ||||
Seed | Dec 1, 2018 |
Key People
Founding team and executive leadership
TreeFrog Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Leonard Green & Partners | Series B |
| European Commission | Grant |
| Bpifrance | Grant, Series B |
| European Investment Bank Group | Debt |
| Aquiti Gestion | Series A, Seed |
| Galia Gestion | Series A |
| XAnge | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2025
Stem cell encapsulator moves from R&D to GMP manufacturing.
- Oct 1, 2025
Collaborating with Vertex Pharmaceuticals on C-STEM technology for diabetes treatment.
TreeFrog Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TreeFrog Therapeutics's valuation, stock price, and market status.
